期刊
HUMAN MOLECULAR GENETICS
卷 23, 期 15, 页码 3975-3989出版社
OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddu112
关键词
-
资金
- German National Genome Network (German Ministry for Education and Research) [NGFNplus 01GS08134]
- ERA-Net NEURON - MIPROTRAN
- french Agence Nationale de la Recherche
Lewy bodies, a pathological hallmark of Parkinson's disease (PD), contain aggregated alpha-synuclein (alpha Syn), which is found in several modified forms and can be discovered phosphorylated, ubiquitinated and truncated. Aggregation-prone truncated species of alpha Syn caused by aberrant cleavage of this fibrillogenic protein are hypothesized to participate in its sequestration into inclusions subsequently leading to synaptic dysfunction and neuronal death. Here, we investigated the role of calpain cleavage of alpha Syn in vivo by generating two opposing mouse models. We crossed into human [A30P]alpha Syn transgenic (i) mice deficient for calpastatin, a calpain-specific inhibitor, thus enhancing calpain activity (SynCAST(-)) and (ii) mice overexpressing human calpastatin leading to reduced calpain activity (SynCAST(+)). As anticipated, a reduced calpain activity led to a decreased number of alpha Syn-positive aggregates, whereas loss of calpastatin led to increased truncation of alpha Syn in SynCAST(-). Furthermore, overexpression of calpastatin decreased astrogliosis and the calpain-dependent degradation of synaptic proteins, potentially ameliorating the observed neuropathology in [A30P]alpha Syn and SynCAST(+) mice. Overall, our data further support a crucial role of calpains, particularly of calpain 1, in the pathogenesis of PD and in disease-associated aggregation of alpha Syn, indicating a therapeutic potential of calpain inhibition in PD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据